Opinion
If someone’s had a
really good response
to a VEGF-TKI or
if they have a low
disease burden
to start out with,
and now they’re
slowly progressing,
I typically will go for
the PD-1 therapy
Dr Tanya Dorff
on second line
RCC treatment
Conference
ELCC 2017
MBCC 2017
JOURNAL SCAN
Association between radiation
therapy, surgery, or observation for
localized prostate cancer and patient-
reported outcomes after 3 years
Lenalidomide maintenance compared
with placebo in responding elderly
patients with diffuse large B-cell
lymphoma treated with first-line
rituximab plus cyclophosphamide,
doxorubicin, vincristine, and prednisone
Clinical calculator for early mortality
in metastatic colorectal cancer: an
analysis of patients from 28 clinical
trials in the Aide et Recherche en
Cancérologie Digestive Database
Prophylactic
cranial irradiation vs
observation in patients
with extensive-disease
small-cell lung cancer
VOL. 1 • NO. 1 • 2017
OUR EXPERTS. YOUR PRACTICE.
ISSN 2207-869X